Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile
Provider: Zacks Investment Research Inc.
Provider: Zacks Investment Research Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

ZS Pharma Inc announces pricing of initial public offering

Tuesday, 17 Jun 2014 07:36pm EDT 

ZS Pharma Inc:Prices initial public offering of 5,944,444 shares of its common stock at price to public of $18.00 per share.Shares are expected to begin trading on NASDAQ Global Market on June 18, under symbol ZSPH.In addition, ZS Pharma has granted underwriters 30-day option to purchase up to an additional 891,667 shares of common stock at initial public offering price, less underwriting discounts and commissions.Expects offering to close on or about June 23.J.P. Morgan Securities LLC and Credit Suisse Securities (USA) LLC are acting as joint book-running managers for offering.BMO Capital Markets Corp. is acting as lead manager and William Blair & Company, L.L.C. is acting as co-manager. 

Company Quote

2.14 +5.54%
21 Nov 2014